Pyrimidine derivatives as 5ht2c-receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/70 (2006.01) A61K 31/505 (2006.01) C07D 401/04 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 471/04 (2006.01) C07D 491/04 (2006.01) C07D 491/052 (2006.01) C07D 495/04 (2006.01)

Patent

CA 2233003

The disclosed pyrimidine derivatives, and pharmaceutically acceptable salts thereof, exhibit useful pharmacological properties, in particular use as 5HT2C- receptor antagonists. The invention is also directed to formulations and methods for treatment.

Les dérivés de pyrimidine décrits, et leurs sels, acceptables sur le plan pharmaceutique, démontrent des propriétés pharmacologiques utiles, notamment en tant qu'antagonistes du récepteur de 5HT¿2C?. L'invention concerne également des formulations et procédés de traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrimidine derivatives as 5ht2c-receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine derivatives as 5ht2c-receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives as 5ht2c-receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1499092

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.